INTRODUCTION
Endogenously produced reactive oxygen species (ROS) are widely believed to play an important role in health and disease. One species of particular interest is hydrogen peroxide (H 2 O 2 ), which is traditionally implicated in "oxidative stress" but also plays a role in physiological signal transduction (1) . H 2 O 2 emitted from mitochondria may be a signal that links mild mitochondrial dysfunction (as may occur during physical exercise or calorie restriction) to health benefits, through the induction of cytoprotective pathways, a concept now known as "mitohormesis" (2, 3). The main mechanism by which H 2 O 2 modulates cellular behavior is through selective protein thiol oxidation, which is antagonized by the NADPH (reduced form of nicotinamide adenine dinucleotide phosphate)-dependent thiol reducing systems. Glutathione (GSH) is the dominant lowmolecular weight thiol in mammalian cells. Differences or changes in the extent of GSH oxidation are considered to indicate shifts in endogenous "redox balance." The development of genetically encoded fluorescent probes for H 2 O 2 (4, 5) and for the GSH redox potential (E GSH ) (6) represents a major advance that enabled analysis of subcellular compartmentspecific real-time information from within living cells and from whole organisms (7, 8) . Compartmental localization and chemical specificity of redox sensors are crucial for obtaining meaningful insights from redox measurements (9, 10) .
The use of fluorescent proteins transgenically expressed in multicellular organisms is limited by optical accessibility. Consequently, transgenic redox reporters have been primarily used in model animals that are either small or translucent or both (7, 11, 12) . For mice, direct in vivo imaging with fluorescent biosensors is limited to superficial tissues or to those tissues that can be accessed by surgical intervention (8) . Thus, redox imaging methods are needed that are more broadly applicable to mouse studies. For example, commonly encountered questions include whether genetic alterations, infections, aging, exercise, changes in diet, toxins, or pharmacological treatments lead to redox changes in vivo. It is imperative to discover within which organs, tissues, cell types, and subcellular organelles these redox changes occur. Hence, we looked for a procedure that preserves the endogenous state of genetically encoded redox probes in the context of histological tissue sections, thus providing sectional "redox maps" for any organ or tissue of interest. This approach would be limited to providing "snapshots" at selected time points but enables the comparison of the effect of many conditions or treatments on redox status in most mouse models and in most tissues with subcellular resolution.
We present a procedure that enables the preservation and visualization of the redox state of an expressed biosensor in mouse tissue sections. We demonstrate the method with tissue sections from mice expressing a mitochondrially targeted fusion protein of redox-sensitive green fluorescent protein 2 and the oxidant receptor peroxidase 1 (mito-roGFP2-Orp1), which is an H 2 O 2 biosensor (4), or a mitochondrially targeted fusion protein of glutaredoxin 1 and redox-sensitive green fluorescent protein 2 (mitoGrx1-roGFP2), which is a biosensor for E GSH (6) . In this procedure, cryogenic tissue sections are exposed to a chemical that maintains the redox state of the expressed biosensors by protecting them from oxidation by atmospheric oxygen, fixatives, or other influences. Briefly, the organ of interest is snap-frozen and cryosectioned, and the sections are immediately immersed in N-ethylmaleimide (NEM), a fast-acting membranepermeable alkylating agent, to clamp the redox state of roGFP2 within the cryosection. Alkylation rapidly and irreversibly traps reduced biosensor molecules in the reduced state, preventing ex vivo oxidation by atmospheric oxygen or paraformaldehyde (PFA) treatment, thus enabling subsequent fixation and storage. The process of cryogenic followed by chemical preservation effectively prevented probe oxidation and preserved reduced tissues in their reduced state. We introduced roGFP2-based redox probes into mice by three different means: tumor xenografting, adenoviral gene transfer, and transgenesis. To illustrate the usefulness and scope of the approach, we assessed redox differences within tumor tissues, redox changes that occur during embryonic development, and redox changes caused by inflammation or nutrient starvation.
RESULTS

Redox imaging of xenografted tumors
To validate the cryogenic chemical probe preservation technique (Fig. 1A) , we first used a tumor xenograft model. We established a human non-small cell lung cancer cell line (H1975) stably expressing the mitochondrial H 2 O 2 biosensor mito-roGFP2-Orp1 (4). The Orp1 domain facilitates roGFP2 oxidation in the presence of H 2 O 2 (Fig. 1B) ; thus, the ratio of oxidized to reduced roGFP2 is a function of H 2 O 2 concentration, which changes fluorescence emission. We confirmed proper mitochondrial localization ( Fig. 2A) and dynamic responsiveness to either exogenous (Fig. 2B ) or endogenous oxidants (Fig. 2C) as induced by respiratory chain inhibitors (rotenone or antimycin A) in the H1975 cells. We showed that pretreatment of the cultured cells with NEM prevented PFA-induced oxidation of the biosensor (Fig. 2, D and E). Athymic nude mice injected subcutaneously with the mito-roGFP2-Orp1-expressing H1975 cells developed tumors, which we harvested, snap-froze with liquid nitrogen, and cryosectioned. Treatment of sections with the oxidant diamide (DA) or the reductant dithiothreitol (DTT) before exposure to NEM confirmed that the 405/488-nm fluorescence ratio increased upon DA treatment and decreased upon DTT treatment ( fig. S1, A and B) . The ratio difference between the fully oxidized (DA treatment) and fully reduced (DTT treatment) samples defined the dynamic range of the biosensor in the tissue ( fig. S1B ). Using the cryogenic chemical preservation protocol, we mapped the relative degree of probe oxidation (OxD roGFP2 ) in different regions of the tumor mass (Fig. 2F) . The necrotic core (Fig. 2, F and G, iii), identified by low nuclear density in hematoxylin and eosin stained serial sections, exhibited almost full probe oxidation. In the nonnecrotic regions, the roGFP2 redox state was heterogeneous, ranging from almost completely reduced to fully oxidized (Fig. 2, F and G, i and ii). These differences may arise from clonal or metabolic heterogeneity within the tumor mass, possibly associated with differences in oxygen or nutrient availability.
Comparison of the biosensor redox state in tissue sections prepared with or without NEM (the chemical step of the cryochemical protocol) before fixation with PFA showed that without the NEM step, PFA partially oxidized the biosensor (Fig. 2, H and I ). As expected, the biosensor remained in the oxidized state in highly oxidized intratumoral regions regardless of NEM treatment (Fig. 2, H and I) . Thus, NEM treatment of the sections prevented PFA-induced probe oxidation.
Redox imaging of mouse liver after adenovirus-mediated probe transduction
Next, we used adenovirus-mediated gene transfer through tail vein injection to express the mito-roGFP2-Orp1 biosensor in the liver. Proper mitochondrial localization of the biosensor ( fig. S2A) , responsiveness of the biosensor to complete oxidation by DA and complete reduction by DTT ( fig. S2 , B and C), and preservation of biosensor redox state by NEM treatment ( fig. S2 , D and E) were confirmed in liver tissue sections. To investigate the influence of liver inflammation on the mitochondrial probe redox state, we injected mice with either tumor necrosis factor-a (TNFa), lipopolysaccharide, or concanavalin A and compared the redox state of the biosensor to the control condition of phosphate-buffered saline (PBS) injection. All three inflammatory compounds produced heterogeneous effects with increased biosensor oxidation in a sparse population of cells (Fig. 3A) , correlating with limited signs of liver damage at the time of analysis ( fig. S3A ). On the basis of the fluorescence ratio measured in individual cells ( fig. S3B ), we calculated OxD roGFP2 (Fig. 3B) , which revealed substantial probe oxidation in individual cells within the population.
To demonstrate the possibility of combining redox probe measurements with conventional immunohistochemistry, we stained representative cryogenic chemical-preserved and PFA-fixed sections from mice injected with TNFa with an antibody against complement receptor type 3 (CD11b), a protein present on phagocytes in a clustered pattern. Although not every cell in the tissue will be infected with the virus encoding the biosensor, we expect that both the hepatocytes and the macrophages can be infected with the virus and express the biosensor. Indeed, we observed regions of biosensor oxidation that colocalized with CD11b staining, implicating macrophages as a source of H 2 O 2 (Fig. 3, C and D) . These results showed that the NEM preservation step is compatible with at least some antibodies and thus can be combined with immunohistochemistry.
Redox imaging of brain and embryonic tissues from biosensor transgenic mice
We applied the cryogenic chemical preservation method to analyze deep solid tissues from biosensor transgenic mice. We used transgenic mice expressing a mitochondrial E GSH probe (6) under a neuron-specific promoter (Thy1-mito-Grx1-roGFP2), as previously characterized and used for in vivo two-photon imaging of the spinal cord (8) . Similar to the H 2 O 2 biosensor, the mito-Grx1-roGFP2 probe localizes to the mitochondria and uses roGFP2 as the fluorescent reporter. In this case however, the attached Grx1 moiety catalyzes the redox equilibration between roGFP2 and GSH, thus yielding a measure of E GSH (Fig. 1B) . After confirming that the cryogenic chemical preservation method was effective with this biosensor in this tissue ( fig. S4 , A to D), we examined the OxD roGFP2 status in hippocampal sections. Ratiometric imaging of cryogenic chemically preserved hippocampus sections revealed that dentate gyrus (GD) granule cells are associated with a more reducing E GSH than pyramidal cells in the cornu ammonis 1 (CA1), CA2, and CA3 regions (Fig. 4 , A to C). We also generated mice expressing the H 2 O 2 probe mito-roGFP2-Orp1 globally (ROSA26/CAG-stop fl -mito-roGFP2-Orp1 × CMV-Cre). The cryogenic chemical preservation method preserved the status of the biosensor in reduced tissues, as exemplified for choroid plexus brain sections (Fig. 5, A and B) , and prevented biosensor oxidation within liver tissue sections (Fig. 5C ). We used this globally expressed biosensor to evaluate the redox status of tissues in early embryos. Because of the small diameter of early embryos, we treated the whole embryos sequentially with NEM and PFA before cryosectioning. We detected globular regions of increased biosensor oxidation in the livers of E12.5 (embryonic day 12.5) embryos (Fig. 5D and fig. S5 ). These regions likely represent clusters of proliferating or differentiating cells because both hematopoietic stem cell differentiation and hepatocyte proliferation are suggested to involve increased production of H 2 O 2 (13) (14) (15) . With adult mito-roGFP2-Orp1 transgenic mice, we also compared muscle tissues from fed and starved animals using the cryogenic chemical preservation method. Starvation increased the oxidation of the biosensor (Fig. 5, E and F, and fig. S6, A and B) , consistent with the enhanced fatty acid oxidation (16) that occurs under these conditions and with the suggestion that starvation-induced oxidants trigger autophagy, thus leading to skeletal muscle atrophy during nutrient deprivation (17) . In muscle sections from starved mice, oxidative and glycolytic muscular fibers (as differentiated by mitochondrial content) exhibited comparatively high and low probe oxidation, respectively (Fig. 5, G and H, and fig. S6 , C and D).
DISCUSSION
The widespread application of genetically encoded fluorescent redox probes to mouse preclinical models has been limited because most organs and tissues are not optically accessible in the living organism. Here, we showed that a simple chemical exposure procedure can be combined with cryosectioning to preserve the redox state of the genetically encoded biosensor and, thus, reveal the spatial distribution of probe redox states in tissue sections from mice (or xenotransplantated tumors) expressing roGFP2-based redox biosensors. The chemical preservation step involves exposing the cryosectioned tissue samples to the membrane-permeable thiol-alkylating agent NEM, which combines several favorable properties. First, NEM by itself does not interfere with roGFP2 fluorescence measurements, neither in the unconjugated nor in the roGFP2-conjugated state (6) . Second, NEM protects the reduced probe from oxidation by irreversibly alkylating the roGFP2 cysteines, thus locking any reduced roGFP2 in the disulfide-free state. Third, NEM treatment additionally protects against reduction of oxidized roGFP2 because NEM generally alkylates free thiols, thus preventing reduction of oxidized roGFP2 by disulfide exchange with thiols contained within the tissue section. Fourth, NEM penetrates tissues rapidly and efficiently, especially when applied to thin sections that are only a few cell layers in diameter. The sections become alkylated very rapidly due to short diffusion distances and simultaneous exposure to NEM from both sides.
The roGFP2 disulfide can still be reduced within the NEM-treated section if a sufficiently large excess of reductant (for example, DTT) is applied, because the exogenous reductant will penetrate the section, consume any remaining free NEM, and then reduce any disulfide bonds (including those in roGFP2). However, this is neither a concern nor relevant to our procedure because reductive equivalents will not spontaneously reemerge within NEM-treated tissue sections unless an exogenous reductant is applied. In our hands, NEM-treated and PFA-fixed tissue sections did not show changes in the roGFP2 fluorescence ratio when stored at −80°C for prolonged periods of time.
We also showed that roGFP2 fluorescence imaging can be combined with conventional immunohistochemistry, thus expanding the scope of the technique and potentially enabling the identification of specific cell types associated with oxidative changes. In principle, antibody binding to a cysteinecontaining epitope could be lost after modification of the epitope by NEM; thus, each epitope-antibody combination will need to be empirically tested. However, we anticipate that such loss of epitope recognition is the exception. Although we have only used mitochondrially targeted probes in this study, the procedure should equally apply to roGFP2-based biosensors targeted to other compartments (including the cytosol), as long as they provide a sufficient signal-to-noise ratio. A specific advantage of roGFP2-based probes is their ratiometric insensitivity to pH changes (10), which is a major drawback for any probe on the basis of circularly permuted fluorescent proteins (18) (19) (20) combination of advantageous properties integral to genetically encoded probes. Moreover, in vivo applications of chemical probes often suffer from pharmacokinetic constraints and may give rise to artifacts by tissueor cell type-specific differences in uptake or export.
Limitations that generally apply to genetically encoded reporters also apply to the redox probes used in this study (10, 21) . We mention one potentially important limitation in the context of histological redox imaging, which is probe sensitivity. The H 2 O 2 -sensitive probe roGFP2-Orp1 is of similar sensitivity as the HyPer probe (4) but is less sensitive than peroxiredoxin-2, which is one of the most H 2 O 2 -sensitive proteins in mammalian cells (22) . As shown here and elsewhere (7), numerous phenomena, related to both stress and signaling situations, can be detected with the roGFP2-Orp1 biosensor. Yet, detection of the slightest (metabolic) H 2 O 2 fluctuations, close to the steady-state baseline, presumably taking place in the low nanomolar or even picomolar range, will probably require the development of peroxiredoxin-based redox probes. Peroxiredoxins are increasingly recognized to engage in redox signaling relays (23) and therefore should also be able to communicate their redox state to roGFPs. In any case, the protocol described herein will also apply to future probes operating on the basis of roGFP2.
In summary, the key advantages of genetically encoded redox probes, namely, precise cellular and subcellular targetability, chemical specificity, and ratiometric measurement, are made available to a broad range of histological studies. The chemical conservation approach should be applicable to investigate the occurrence of redox differences and changes under various physiological and pathological conditions. For example, it is often suggested that most cancer cells exhibit increased endogenous ROS generation, leading to either increased steady-state levels or increased turnover of ROS. This has led to the idea that drugs that further enhance ROS generation (or selectively inhibit reducing systems) will push tumor cells over their tolerable threshold of oxidative stress, thus triggering selective cell death (24) . However, in previous intervention studies, it remained mostly unknown to which extent drugs actually reached different parts of a tumor, to which extent redox changes were actually inflicted in situ, and to which extent tumor cells responded differently relative to the surrounding healthy tissues. Histological redox imaging should enable the reliable investigation of how tumors and their surroundings respond to prooxidative or antireductive drugs, alone, or in combination with conventional radio-or chemotherapy. It will also be of interest to study the redox response of healthy and tumor tissues to compounds presumed to act as "antioxidants," given recent findings suggesting that such compounds may accelerate tumor progression and promote metastasis (25) (26) (27) .
MATERIALS AND METHODS
Cell culture
Phoenix-AMPHO and human embryonic kidney-293 cells were grown in Dulbecco's modified Eagle medium (Invitrogen). H1975 non-small cell lung carcinoma cells (obtained from American Type Culture Collection) were grown in RPMI 1640 (Invitrogen). Media were supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Invitrogen), 2 mM L-glutamine (Invitrogen), penicillin (100 U/ml), and streptomycin (100 mg/ml) (Invitrogen). Cells were incubated in a humidified atmosphere of 5% CO 2 /95% air at 37°C.
Stable expression of mito-roGFP2-Orp1 in H1975 cells
H1975 cells stably expressing mito-roGFP2-Orp1 were established by retroviral transduction. Briefly, Phoenix-AMPHO cells were transfected with pLPCX/mito-roGFP2-Orp1 (encoding the roGFP2-Orp1 probe with an N-terminal mitochondrial targeting sequence) by the calcium phosphate method. After 6 hours of transfection, cells were washed twice with PBS and transferred to fresh medium. After 24 and 48 hours of transfection, supernatant was collected and passed through a 0.22-mm filter. H1975 cells (seeded at 2.7 × 10 5 cells per well in a six-well plate for 24 hours before each experiment) were incubated with the virus-containing supernatant supplemented with Polybrene (4 mg/ml) for 24 hours at 37°C in a 5% CO 2 atmosphere. Cells were then grown in medium containing puromycin (0.5 mg/ml) for several days. A highly fluorescent cell population (~6% of overall population) was selected by flow cytometry (FACSAria). Collected cells were expanded in the medium containing puromycin (0.5 mg/ml) and gentamycin (50 mg/ml).
Subcellular localization of mito-roGFP2-Orp1
Targeting of mito-roGFP2-Orp1 to mitochondria was confirmed by colocalization with TMR (Molecular Probes). Cells placed in cell culture dishes (FluoroDish, World Precision Instruments) were washed twice with Dulbecco's PBS (Invitrogen) and incubated with TMR in Hanks' balanced salt solution (Invitrogen) for 20 min at 37°C. roGFP2 fluorescence was excited with the 488-nm laser line and TMR fluorescence with the 543-nm laser line on a Zeiss LSM 710 ConfoCor 3 microscope equipped with a Plan-Apochromat 63×/1.40 NA (numerical aperture) DIC (differential interference contrast) oil immersion objective.
In vitro characterization of H1975 cells expressing mito-roGFP2-Orp1
H1975 cells expressing mito-roGFP2-Orp1 (4 × 10 4 ) in 400 ml of RPMI/ 10% FBS/25 mM Hepes were seeded into the wells of a Lab-Tek Chamber Slide (Fisher Scientific GmbH) 1 day before the experiment. Images were obtained with a Zeiss LSM 710 ConfoCor 3 microscope equipped with an EC Plan N DICI 40×/1.3 NA objective (oil immersion) and a ZEN software. roGFP2 fluorescence was excited sequentially at 405 and 488 nm (line by line) followed by the detection of the emission through the 500-to 550-nm bandpass filter. Real-time measurements were conducted in time series mode under 5% CO 2 at 37°C. After three 15-s intervals, 200 ml of medium containing the compound of interest (H 2 O 2 , rotenone, or antimycin A; at 2× final concentration) was added to the cells. Subsequent images were obtained every 15 s.
Animal experiments
Animal experiments were conducted according to local, national, and European Union ethical guidelines and approved by local regulatory authorities.
Xenograft experiments
Five-week-old female NMRI (Naval Medical Research Institute) (nu/nu) mice (Charles River Laboratories) were used for xenografting. After 1 week of acclimatization to individually ventilated cages, Kliba chow 3307 and water ad libitum, 5 × 10 6 H1975 cells expressing mitoroGFP2-Orp1 were injected subcutaneously. Tumors were allowed to grow up to a size of 15 mm in one diameter, followed by embedding into Tissue-TEK OCT (optimal cutting temperature) compound and snap-freezing in isopentane/liquid nitrogen before storage at −80°C.
Preparation of recombinant adenovirus
Adenovirus expressing mito-roGFP2-Orp1 was generated using a modified pAd-BLOCK-iT vector system (Invitrogen). The mito-roGFP2-Orp1 coding sequence was subcloned into a pENTR entry vector modified to express the probe under control of the CMV (cytomegalovirus) promoter, followed by integration into pAd/BLOCK-iT-DEST. Adenoviruses expressing mito-roGFP2-Orp1 were produced using the BLOCK-iT Adenoviral RNAi Expression System (Invitrogen) according to the manufacturer's instructions and purified by cesium chloride gradient (28) .
In vivo gene transfer and induction of liver inflammation
Male C57BL/6 mice (Charles River Laboratories) were maintained on a 12-hour light-dark cycle with regular unrestricted diet. After 7 days, 2 × 10 9 plaque-forming units of adenovirus were administered by tail vein injection. After another week, mice were subjected to the following treatments: intraperitoneal injection of 1 mg of recombinant mouse TNFa (410-MT, R&D Systems) and lipopolysaccharide (20 mg/kg) (055:B5) (L4524, Sigma-Aldrich) and intravenous injection of concanavalin A (40 mg/kg) (L7647, Sigma-Aldrich). PBS was injected as vehicle treatment. Mice were sacrificed and analyzed 8 hours after the injection of inflammatory mediators.
Generation of transgenic mice
The generation of mice expressing mito-Grx1-roGFP2 under control of the Thy1 promoter has been described previously (8) . To generate mitoroGFP2-Orp1-expressing mice, roGFP2-Orp1 with a cyclooxygenase 8 (COX8) mitochondrial targeting sequence (Neurospora crassa) was cloned into a modified version of the targeting vector pROSA26-1 (29) (a gift from M. Schmidt-Supprian) using Asc I and Sma I restriction sites. The resulting targeting vector contains a CAG promoter, a loxP-flanked neo r -stop cassette, the COX8-roGFP2-Orp1 construct, and a polyadenylation sequence (pROSA26-CAG-loxP-Stop-loxP-AscI-COX8-roGFP2-Orp1-SmaI-polyA). Electroporated JM8.A3 embryonic stem (ES) cells (30) were selected with neomycin, and positive clones were microinjected into C57BL/6N blastocysts and further processed as described by Pettitt and colleagues (30) . Chimeric mice were bred for homozygous transgene insertion, crossed with CMV-Cre mice, and then selected for homozygous deletion of the stop cassette.
Preparation of adult murine tissue or tumor sections
Harvested tissues were embedded in Tissue-Tek OCT compound and snap-frozen in isopentane/liquid nitrogen before storage at −80°C. Embedded tissues were warmed to −20°C (brain tissue) or to −25°C (other tissues), cryosectioned into 14-mm slices with a cryotome (Leica CM3050), and mounted onto Superfrost Plus slides (Fisher Scientific GmbH). For sections further processed with chemicals, the chemicals were applied immediately after mounting. To induce maximal probe oxidation or reduction, sections were incubated for 10 min at 4°C with 50 ml of PBS (10.1 mM NaHPO 4 , 1.8 mM KH 2 PO 4 , 136.8 mM NaCl, 2.7 mM KCl) containing 1 mM DA or 10 or 20 mM DTT, respectively, before NEM treatment. To preserve the endogenous redox state, sections were immediately incubated with 80 to 100 ml of PBS containing 50 mM NEM (E3876, Sigma-Aldrich) for 10 min at 4°C followed by fixation in 4% PFA in PBS containing 1 mM TO-PRO-3 (using 0.1% dimethyl sulfoxide as a co-solvent) (T3605, Invitrogen) for 15 min at ambient temperature. PFA was washed out twice with ice-cold PBS for 5 min. Sections were then mounted in Mowiol mounting medium [17% (w/w) Mowiol 4-88 in PBS/glycerol (2:1, v/v)] and kept at 4°C until use.
Immunofluorescence
To detect CD11b, after the fixation step (4% PFA in PBS), sections were washed twice with ice-cold PBS for 5 min and immediately incubated for 60 min in blocking buffer [5% normal goat serum (5425, Cell Signaling Technology) in PBS]. Sections were subsequently incubated with an antibody against CD11b conjugated to Alexa Fluor 594, which was diluted (1:1500) in PBS with 1% bovine serum albumin (BSA). Sections were incubated overnight at 4°C in a humid light-tight box. Sections were washed three times with PBS and mounted using ProLong Gold Antifade Reagent (8961, Cell Signaling Technology). Microscopy images were taken within 24 hours.
To detect MnSOD (manganese superoxide dismutase), livers were fixed overnight with 4% PFA immediately after excision. Sections (50-mm thickness) prepared by vibratome were rinsed three times with ice-cold PBS for 5 min and incubated for 60 min in blocking buffer (5% normal goat serum and 0.25% Triton X-100 in PBS) at room temperature. Sections were subsequently incubated with an antibody against MnSOD (ADI-SOD-110, StressGen) in an antibody dilution buffer (1% BSA and 0.25% Triton X-100 in PBS) for 20 hours at 4°C. Sections were washed three times in PBS for 5 min and incubated in antibody dilution buffer with a secondary antibody against rabbit immunoglobulin G conjugated to Alexa Fluor 594 (A11012, Invitrogen) (1:300) for 2 hours at room temperature in the dark. Sections were incubated in PBS containing 0.5 mM TO-PRO-3 for 20 min, rinsed three times in PBS for 5 min, and mounted in Mowiol mounting medium.
Starvation
Mice were maintained on a 12-hour light-dark cycle in a temperaturecontrolled barrier facility, with free access to water and food. To examine the effects of fasting, 12-week-old female mice (mito-roGFP2-Orp1-expressing or controls) were fasted for 22 to 24 hours or fed ad libitum. After this period, the gastrocnemius and soleus muscles were dissected, promptly embedded into Tissue-Tek OCT compound, and snap-frozen in isopentane/liquid nitrogen before storage at −80°C. Sections were processed as follows: muscle sections were incubated with 50 ml of PBS or PBS containing 50 mM NEM for 10 min at 4°C followed by fixation in 4% PFA in PBS for 30 min at room temperature. PFA was rinsed twice with ice-cold PBS for 10 min. Sections were then mounted in Mowiol mounting medium [17% (w/w) Mowiol 4-88 in PBS/glycerol (2:1, v/v)] and kept at 4°C until use. Microscopy images were taken within 24 hours after sectioning. Mice lacking biosensor expression (ROSA26/CAG-stop flmito-roGFP2-Orp1 with intact stop cassette) were used as autofluorescence background controls.
Preparation of embryonic tissue sections
At E12.5, embryos were collected, immediately immersed in PBS containing freshly dissolved NEM (100 mM), and incubated for 1.5 hours at 4°C. Embryos were then fixed in 4% PFA in PBS (pH 7.4) plus 100 mM NEM for 1.5 hours at room temperature. Embryos were washed two times in PBS for 10 min, embedded in Tissue-Tek OCT compound, and snapfrozen in isopentane/liquid nitrogen before storage at −80°C. The embryos were oriented to obtain a longitudinal section of the whole animal. At the day of the experiment, the samples were removed from −80°C and kept at −20°C for 1 hour before sectioning. Sections of 14-mm thickness were cut by cryostat, mounted on Superfrost Plus slides (Fisher Scientific GmbH), and dried for 5 min at room temperature. Sections were then mounted in Mowiol mounting medium and kept at 4°C until use. Microscopy images were taken within 24 hours after sectioning.
Image acquisition and image acquisition controls
Guidelines for the use of roGFP2-based redox probes, including microscopy settings and image analysis, have been provided previously (31, 32) . In general, fluorescence images were acquired frame by frame by measuring emission at 520 to 540 nm and exciting sequentially with the 405-and 488-nm laser lines. For each animal, at least two images were taken from one or more sections. For starvation experiments, images were acquired using a 40× objective. Tumor, coronal hippocampus, liver, and embryo images were acquired with a 20× objective on a Leica TCS SP5 inverted confocal microscope using automated tile scanning with 10% overlap between individual images. To control for autofluorescence in tissue sections, we used two approaches. First, control images were taken from tissues lacking biosensor expression (ROSA26/CAG-stop fl -mitoroGFP2-Orp1 mice with intact stop cassette or mice injected with PBS instead of adenovirus). These tissues were treated in the same way, and resulting images were used as general autofluorescence background controls. Second, for every sample, an image was acquired with excitation at 405 nm and emission at 460 nm. The resulting autofluorescence image was used for adjusting the background subtraction threshold. Autofluorescence controls were also applied to samples from the developing fetal liver to detect potential autofluorescence of developing blood cells, which showed very weak autofluorescence at all emission wavelengths.
Image processing
In brief, raw image data of the 405-and 488-nm laser lines were exported to ImageJ as 16-bit TIFFs for further analysis. After conversion to 32-bit images, upper and lower thresholds were set for both images to remove background fluorescence and overexposed pixels. Ratio images were created by dividing the 405-nm image by the corresponding 488-nm image pixel by pixel. For visualization of the ratiometric images, the ImageJ lookup table "Fire" was used. For additional quality control, representative images were subjected to detailed inspection and computational analysis as described previously for Drosophila tissues (32) .
Data representation and statistics
Data are represented as either normalized fluorescence ratios (405/488 nm) or as OxD roGFP2 , as box-whisker plot, dot plot, or bar chart. The fluorescence intensity ratio is the primary observable. Raw ratio values depend on the specific experimental conditions (instrument settings) and do not have absolute meaning. They cannot be compared between different experiments unless they are either calibrated relative to both maximum and minimum ratios (formally corresponding to the conversion to OxD) or at least normalized to either the maximum or minimum ratio (labeled "normalized ratio" in our figures). The 405/488-nm raw ratio values were normalized by setting the fully oxidized state (DA control) to 1 (that is, R norm = R obs /R ox ). In most experiments, fully oxidized (DA) and fully reduced (DTT) samples were prepared to allow calculation of the degree of probe oxidation. The OxD is the ratio of the number of oxidized molecules to the total number of molecules (OxD roGFP2 = [roGFP2 ox ]/ ([roGFP2 red ] + [roGFP2 ox ])). The conversion of raw fluorescence intensities to OxD values was done as previously described (33) . In our figures, OxD is expressed as a percentage. In box-whisker plots, data represent median values with a box for the interquartile range and whiskers for the 5th/95th percentiles. Bar diagrams represent normalized ratios as means ± SEM. In single-cell analyses, 30 cells per sample were randomly collected as individual regions of interests, and measurements were represented as dot plot. The sample size (n) represents the number of samples used for statistics. Student's t test was used for binary comparisons. Statistical significance was defined as *P < 0.05, **P < 0.01, and ***P < 0.001.
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